These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32237046)

  • 1. Evaluation of the introduction of a 'traffic light protocol' for dose-volume histogram constraints of organs at risk in definitive radiotherapy at Liverpool and Macarthur Cancer Therapy Centres.
    Kasraei F; Ochoa C; Vial P; Lee MT
    J Med Imaging Radiat Oncol; 2020 Jun; 64(3):427-434. PubMed ID: 32237046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
    Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans-Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise.
    Cloak K; Jameson MG; Paneghel A; Wiltshire K; Kneebone A; Pearse M; Sidhom M; Tang C; Fraser-Browne C; Holloway LC; Haworth A
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):390-398. PubMed ID: 30950223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.
    Li N; Carmona R; Sirak I; Kasaova L; Followill D; Michalski J; Bosch W; Straube W; Mell LK; Moore KL
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):164-172. PubMed ID: 27979445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-shaping using targeted sparse optimization.
    Sayre GA; Ruan D
    Med Phys; 2013 Jul; 40(7):071711. PubMed ID: 23822415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.
    Moore KL; Schmidt R; Moiseenko V; Olsen LA; Tan J; Xiao Y; Galvin J; Pugh S; Seider MJ; Dicker AP; Bosch W; Michalski J; Mutic S
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):228-35. PubMed ID: 25847605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessing dose constraints of organs at risk in children with abdominal neuroblastoma treated with definitive radiation therapy: a correlation with late toxicity.
    Kandula S; Sutter A; Prabhu RS; Jegadeesh N; Esiashvili N
    Pediatr Blood Cancer; 2015 Jun; 62(6):970-5. PubMed ID: 25545501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
    Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
    Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implement a knowledge-based automated dose volume histogram prediction module in Pinnacle
    Xu H; Lu J; Wang J; Fan J; Hu W
    J Appl Clin Med Phys; 2019 Aug; 20(8):134-140. PubMed ID: 31343821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of quality assurance rounds in a Canadian radiation therapy department.
    Lefresne S; Olivotto IA; Joe H; Blood PA; Olson RA
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e117-21. PubMed ID: 23195781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
    Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy.
    Zhang P; Fan N; Shan J; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2017 Sep; 18(5):29-35. PubMed ID: 28681976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program.
    Rouette J; Gutierrez E; O'Donnell J; Reddeman L; Hart M; Foxcroft S; Mitera G; Warde P; Brundage MD; ;
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):521-529. PubMed ID: 28258891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting dose-volume histograms for organs-at-risk in IMRT planning.
    Appenzoller LM; Michalski JM; Thorstad WL; Mutic S; Moore KL
    Med Phys; 2012 Dec; 39(12):7446-61. PubMed ID: 23231294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.
    Al-Hallaq HA; Chmura SJ; Salama JK; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Robinson CG; Pisansky TM; Winter KA; White JR; Xiao Y; Matuszak MM
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):155-163. PubMed ID: 27843033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for a priori estimation of best feasible DVH for organs-at-risk: Validation for head and neck VMAT planning.
    Ahmed S; Nelms B; Gintz D; Caudell J; Zhang G; Moros EG; Feygelman V
    Med Phys; 2017 Oct; 44(10):5486-5497. PubMed ID: 28777469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of PlanIQ Feasibility DVH for head and neck treatment planning.
    Fried DV; Chera BS; Das SK
    J Appl Clin Med Phys; 2017 Sep; 18(5):245-250. PubMed ID: 28857470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
    Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
    Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.